| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VETMIC.2019.05.018 |
| P698 | PubMed publication ID | 31213273 |
| P50 | author | Mohammed Naghizadeh | Q89151303 |
| P2093 | author name string | Shaban Rahimi | |
| Mohammad Amir Karimi Torshizi | |||
| Ricarda Margarete Engberg | |||
| Tina Sørensen Dalgaard | |||
| P2860 | cites work | Bacteriophage therapy | Q24550616 |
| Experimental phage therapy against Staphylococcus aureus in mice | Q24685170 | ||
| Filamentous bacteriophage fd as an antigen delivery system in vaccination | Q26864071 | ||
| Human and avian extraintestinal pathogenic Escherichia coli: infections, zoonotic risks, and antibiotic resistance trends | Q27007026 | ||
| Encapsulation of Bacteriophage in Liposome Accentuates Its Entry in to Macrophage and Shields It from Neutralizing Antibodies | Q28551599 | ||
| Immunological factors that affect the in vivo fate of T7 phage in the mouse | Q31030911 | ||
| Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials | Q33419859 | ||
| Efficacy of Phage Therapy in Controlling Rabbit Colibacillosis and Changes in Cecal Microbiota | Q33734577 | ||
| Phage neutralization by sera of patients receiving phage therapy | Q33828266 | ||
| Phenotypic and genotypic variations within a single bacteriophage species. | Q33853311 | ||
| Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium | Q34116507 | ||
| Phage therapy: the Escherichia coli experience | Q34431779 | ||
| Immunogenicity studies of proteins forming the T4 phage head surface. | Q34593930 | ||
| Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement | Q34597583 | ||
| Mammalian Host-Versus-Phage immune response determines phage fate in vivo. | Q36123704 | ||
| PEGylation of bacteriophages increases blood circulation time and reduces T-helper type 1 immune response | Q37274884 | ||
| Antibody Production in Response to Staphylococcal MS-1 Phage Cocktail in Patients Undergoing Phage Therapy. | Q37360042 | ||
| Evaluation of the efficacy of chitosan nanoparticles loaded ΦKAZ14 bacteriophage in the biological control of colibacillosis in chickens. | Q37606227 | ||
| Phage as a modulator of immune responses: practical implications for phage therapy | Q38022877 | ||
| The factors affecting effectiveness of treatment in phages therapy | Q38193804 | ||
| Facing antibiotic resistance: Staphylococcus aureus phages as a medical tool | Q38225652 | ||
| Antimicrobial Resistance in Bacterial Poultry Pathogens: A Review | Q38604692 | ||
| Is the Concept of Avian Pathogenic Escherichia coli as a Single Pathotype Fundamentally Flawed? | Q38668716 | ||
| Phage Therapy in Bacterial Infections Treatment: One Hundred Years After the Discovery of Bacteriophages. | Q39023156 | ||
| Prophylactic Bacteriophage Administration More Effective than Post-infection Administration in Reducing Salmonella enterica serovar Enteritidis Shedding in Quail | Q40564917 | ||
| Isolation, identification, and pathogenicity of O142 avian pathogenic Escherichia coli causing black proventriculus and septicemia in broiler breeders | Q41467829 | ||
| Multiple Antimicrobial Resistance of Escherichia coli Isolated from Chickens in Iran | Q41576393 | ||
| The contribution of systemic Escherichia coli infection to the early mortalities of commercial broiler chickens | Q42632734 | ||
| Treatment with high-dose antidepressants severely exacerbates the pathological outcome of experimental Escherichia coli infections in poultry. | Q42650868 | ||
| Immune interference of bacteriophage efficacy when treating colibacillosis in poultry | Q43108014 | ||
| Evaluation of the influence of bacteriophage titer on the treatment of colibacillosis in broiler chickens | Q43856464 | ||
| Molecular epidemiology of avian pathogenic Escherichia coli (APEC) isolated from colisepticemia in poultry | Q45142247 | ||
| An amino acid substitution in a capsid protein enhances phage survival in mouse circulatory system more than a 1000-fold. | Q46627654 | ||
| Efficacy of a bacteriophage isolated from chickens as a therapeutic agent for colibacillosis in broiler chickens | Q50440599 | ||
| Synergistic effect of phage therapy using a cocktail rather than a single phage in the control of severe colibacillosis in quails | Q56985717 | ||
| In vivo efficiency evaluation of a phage cocktail in controlling severe colibacillosis in confined conditions and experimental poultry houses | Q62772296 | ||
| Genetic variation among broiler genotypes in susceptibility to colibacillosis | Q82910172 | ||
| P921 | main subject | phage therapy | Q611870 |
| colibacillosis | Q3682612 | ||
| P1104 | number of pages | 11 | |
| P304 | page(s) | 61-71 | |
| P577 | publication date | 2019-05-24 | |
| P1433 | published in | Veterinary Microbiology | Q15761011 |
| P1476 | title | Effect of serum anti-phage activity on colibacillosis control by repeated phage therapy in broilers | |
| P478 | volume | 234 |
Search more.